Neurogene Inc (NGNE): Rasio kapitalisasi marang pendapatan
Neurogene Inc. utilizes certified international cold chains for the delivery of biocomponents. The scientific team's flexibility is ensured by outsourcing production and testing to external contractors. In-house facilities in Texas and New York guarantee the stability of development. The price-to-sales valuation reflects the price action, where 325.50 determines the current value of the metric.
Rincian metrik lan analitis perusahaan Neurogene Corp (NGNE)
- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi bursa:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Neurogene Inc.|NGNE - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Neurogene Therapeutics|NGNE - Gunggung utang perusahaan|Utang marang nilai buku Neurogene Corp|NGNE - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka cendhak Neurogene|Rasio likuiditas darurat neurogene.com
- data bathi lan kelipatan valuasi:
NGNE - Bathi resik|Proyeksi bathi resik Neurogene Inc.|NGNE - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Neurogene Inc|NGNE - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Neurogene Corp|NGNE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Neurogene|NGNE - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan neurogene.com|NGNE - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Neurogene Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:NGNE (neurogene.com)
To assess long-term overpayment risks for the investor, it is essential to analyze the P/S ratio, which compares the market capitalization of Neurogene Inc. (NGNE) to its annual revenue, identifying phases of market overheating through revenue multiple dynamics. This indicator allows for the correlation of business value with actual earnings, which is critical for a company whose stability is supported by independent research and production facilities in New York and Texas.
Karo sapa Neurogene Inc. saingan
BIIB - Rega marang dodolan|Rasio rega marang pendapatan Neurocrine Biosciences, Inc. NBIX|RGC: Rasio kapitalisasi marang pendapatan|Axsome Therapeutics Inc - Multiplikator P/S|Rega marang dodolan ACADIA Corp|XENE (Xenon Pharmaceuticals) - Kapitalisasi marang pendapatan|vikingtherapeutics.com - Rasio kapitalisasi pasar marang pendapatan|SUPN (Supernus) - Multiplikator P/S|Catalyst Pharma (CPRX) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Denali Therapeutics Inc (DNLI)|Harmony Corp - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BHVN (Biohaven Ltd.)|AMLX - Kapitalisasi marang pendapatan|TRVI: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Praxis Precision Medicines Inc PRAX|Anavex Corp (AVXL) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan CBLL|PRTA (Prothena Biosciences) - Multiplikator P/S|ALEC - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Annexon (ANNX)|omeros.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ACIU (AC Immune Corp)|Voyager Corp (VYGR) - Rega marang dodolan|NMRA - Rasio rega marang pendapatan|SCLX (scilexholding.com) - Rasio kapitalisasi marang pendapatan|TVGN: Multiplikator P/S|Rega marang dodolan Alpha Cognition Inc. (ACOG)|Kapitalisasi marang pendapatan CGTX|Multiplikator P/S Inhibikase Pharma|Rasio rega marang pendapatan Cassava Sciences, Inc. (SAVA)|ASRT (assertiotx.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Coya Therapeutics COYA|VistaGen Therapeutics, Inc. (VTGN) - Rega marang dodolan|OVID - Rasio rega marang pendapatan|ABOS (Acumen Pharmaceuticals, Inc) - Rasio kapitalisasi marang pendapatan|CRVO: Multiplikator P/S|Rega marang dodolan Alterity Therapeutics Limited (ATHE)|Kapitalisasi marang pendapatan CLNN|Multiplikator P/S PepGen Corp|Rasio rega marang pendapatan Jupiter Neurosciences (JUNS)|RLMD (Relmada Corp) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Annovis Bio, Inc. ANVS|Grace Therapeutics Inc (GRCE) - Rega marang dodolan|Firefly Neuroscience - Multiplikator P/S|Multiplikator rega marang pendapatan Klotho Neurosciences Inc (KLTO)|NRSN: Multiplikator P/S|Rega marang dodolan Reviva Pharmaceuticals, Inc. (RVPH)|Rasio rega marang pendapatan MetaVia Inc.|Rasio kapitalisasi marang pendapatan NRXS (neuraxis.com)|Multiplikator P/S HSDT|PASG - Rega marang dodolan|Neuphoria Therapeutics - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan NERV|Athira Pharma, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan addextherapeutics.com ADXN|alzamend.com (ALZN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan CYCN|PTIX (Protagenic Therapeutics Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Pasithea (KTTA)|Kapitalisasi marang pendapatan CRGT (Cortigent, Inc.)|Koefisien rega marang pendapatan avenuetx.com|Rasio rega marang pendapatan BrainStorm Cell Therapeutics BCLI|CARA: Rasio kapitalisasi marang pendapatan|Chromocell Therapeutics Corporation - Multiplikator P/S|Multiplikator rega marang pendapatan Eliem Therapeutics (ELYM)|intracellulartherapies.com (ITCI) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan LBPH|MRNS (Marinus Pharmaceuticals, Inc.) - Multiplikator P/S|Rega marang dodolan NKGen Biotech Inc NKGN|Rasio rega marang pendapatan NeuroBo (NRBO)|Sage Therapeutics Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S SNPX (Synaptogenix, Inc.)|trevena.com (TRVN) - Rega marang dodolan|VIGL: Kapitalisasi marang pendapatan|WENA - Multiplikator P/S|Cerevel (CERE) - Rasio rega marang pendapatan
